MORE ARTICLES
- Microschool First Impressions: Curious Mike & Spencer Blasdale Visit KaiPodJanuary 16, 2025 - 12:00 pm
- McAnneny’s January Musings – Legislative Transparency Takes Center Stage in the New YearJanuary 15, 2025 - 1:55 pm
- Pioneer Institute Statement on MBTA FundingJanuary 15, 2025 - 12:33 pm
- ExcelinEd’s Dr. Kymyona Burk on Mississippi, Early Literacy, & Reading ScienceJanuary 15, 2025 - 11:42 am
- Video Statement of Frank J. Bailey (Ret. Honorable), President of Pioneer Public Interest Law CenterJanuary 14, 2025 - 9:14 am
- The House Call – JanuaryJanuary 13, 2025 - 1:25 pm
- Mapping Mass Migration – Remote Workers: The Most Mobile ResidentsJanuary 9, 2025 - 2:18 pm
- Statement on MBTA Communities Law Milton RulingJanuary 8, 2025 - 3:36 pm
- Harvard’s Leo Damrosch on Alexis de Tocqueville & Democracy in AmericaJanuary 8, 2025 - 9:57 am
- Mapping Mass Migration: Massachusetts Remains a Top Destination for ImmigrantsJanuary 6, 2025 - 10:29 am
Stay Connected!
Receive the latest updates in your inbox.
The Necessity of Transparent Tax Revenue Reporting: MA Provides a Shining Example
/in Blog: Transparency /by Aidan EnrightRevenue collections, predicted revenue, and expenditures are among the most important data points states report. Without accurate predictions and regular reporting, the legislature and governor’s office may go over or under budget, potentially leaving citizens and policymakers in the dark about the fiscal health of the state.
For this reason, all states regularly report those numbers and update estimates based on trends, overall economic conditions, and expected changes as a result of new state policies. However, even among the New England states, the transparency and accessibility of such reporting varies greatly and, as a result, limits analysts’ ability to meaningfully compare state revenues and judge performance in real time.
Genetic Therapy Revolution: Benefits and Barriers for Medicine’s New Horizon
/in Featured, Healthcare, News, Podcast Hubwonk /by Editorial StaffJoe Selvaggi talks with neurobiologist and writer Dr. Anne Sydor about the potential for gene therapy to address deadly and debilitating diseases and how current health care models must adapt to encourage this nascent technology.
Dr. Adrian Mims on The Calculus Project & STEM
/in Education, Featured, Learning Curve, News, Podcast /by Editorial StaffDr. Mims navigates through the contentious “math wars” and underscores the pivotal role of Algebra I as a gateway to higher math. He also evaluates the negative impact of Common Core math standards, and proposes strategies to combat pandemic-induced learning setbacks and bridge the gap in math proficiency between American students and their international counterparts.
Contours of Content Curation: SCOTUS Hears Online Free Speech Cases
/in Featured, News, Podcast Hubwonk /by Editorial StaffCato Institute’s Thomas Berry, talks about oral arguments at the Supreme Court in the NetChoice cases, exploring the First Amendment questions that affect both social media users and the platforms that curate their content.
Boston Children’s, MGH Among Massachusetts Hospitals with Highest Relative Commercial Prices
/in Featured, Health Care, Health Care Policy (MA), Healthcare, News, Pioneer Research /by Editorial StaffPioneer Institute’s new tool, the Massachusetts Hospital Relative Price Tracker, displays relative price and facilitates relative price comparisons among hospitals. The average price among all hospitals will have a relative price of 1.0. A relative price of 1.5 means that a hospital charges 50 percent higher than the average of all Massachusetts hospitals. Similarly, a relative price of 0.84 means that a hospital’s prices are 16 percent below average. Relative price data is collected and reported by the Commonwealth’s Center for Health Information and Analysis (CHIA) and is an aggregate measure used to evaluate price variations among different hospitals. It is recalculated annually based on data collected from commercial payers and includes information on private commercial insurance and commercially managed public insurance products such as Medicare Advantage and Medicaid Managed Organizations/Accountable Care Partnership Plans.